Page last updated: 2024-08-21

oxazoles and temozolomide

oxazoles has been researched along with temozolomide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguado, T; Albiñana, V; Botella, LM; Campuzano, S; Cuesta, ÁM; Garcia-Sanz, JA; Granados, R; Pingarrón, JM; Romero-Revilla, JA; Sánchez-Puelles, JM; Sánchez-Sancho, F; Santamaría, S; Torrente-Rodríguez, RM	1

Other Studies

1 other study(ies) available for oxazoles and temozolomide

Article	Year
11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells. Scientific reports, 2019, 08-15, Volume: 9, Issue:1 Topics: Animals; Antineoplastic Agents; Biosensing Techniques; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Glioma; Magnetic Phenomena; Mammary Glands, Animal; Mice; MicroRNAs; Neoplastic Stem Cells; Oxazoles; Reproducibility of Results; Spheroids, Cellular; Temozolomide; Xenograft Model Antitumor Assays	2019

Article

Year

11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells.

Scientific reports, 2019, 08-15, Volume: 9, Issue:1

Topics: Animals; Antineoplastic Agents; Biosensing Techniques; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Glioma; Magnetic Phenomena; Mammary Glands, Animal; Mice; MicroRNAs; Neoplastic Stem Cells; Oxazoles; Reproducibility of Results; Spheroids, Cellular; Temozolomide; Xenograft Model Antitumor Assays

2019